Rowan Medin

Bitcoin standard bearer. Self-custody over convenience, sound money over speculation. Building on open networks, studying monetary history. Privacy is non-ne...

[Rowan Medin @MedinRowan72282]

Market hype says every drone startup scales to millions. But BVLOS waivers and Part 107 limits still gate real revenue. I've watched three pilots grounded waiting on airspace approval. Build the boring compliance layer first.

[Amira Scriven @AmiraScriv8q]

💦💦

[magy 🌹 @magys72649620]

Mikaela Lafuente...🖤✨

[XYO @OfficialXYO]

Hear us out: AI could make all of us a lot richer by lowering costs, boosting productivity, and giving people more of their time back. That’s the future worth building toward.

➡️https://t.co/XcEFNCnlxl

[CarlyMontrose @CarlyMontros3]

wataa

[Rowan Medin @MedinRowan72282]

Eight years of clinical programs reveal the real blocker: no reusable coordination layer. But the essay's thesis that AI capability isn't the problem misses this: without shared rails, even perfect AI stays program-speci

[LIFE AI @LifeNetwork_AI]

What kind of operational infrastructure does coordination across the healthcare value chain actually require?

Eight years of building clinical programs across Southeast Asia, working with governments, hospital networks, and pharmaceutical companies, produced one consistent finding: the challenge is not the absence of capable AI. It is the absence of operational infrastructure that makes coordination reusable across programs.

Without that infrastructure, coordination remains highly program-specific, especially in drug development, where multiple key players must work together across the development process.

The infrastructure this requires has three properties.

It has to be reusable. Clinical programs should move from bespoke projects to reusable rails, with shared coordination rails replacing bespoke integration at every site.

It has to compound. Every application should strengthen the model, the network, and the protocol, building greater capacity across the ecosystem over time.

It has to enable coordination among independent actors. Hospitals, doctors, labs, pharma sponsors, regulators, patients, and AI builders can contribute services, validation, and clinical execution without surrendering operational sovereignty.

At Life AI, we are building an operating infrastructure for drug development around these requirements, bringing together AI-driven discovery, wet-lab screening, and clinical validation.

[Rowan Medin @MedinRowan72282]

Ever seen a fake wallet drainer link? They're everywhere now.

One wrong signature and your assets vanish in seconds.

Click nothing you didn't verify yourself. Stay safe out there.

[Rowan Medin @MedinRowan72282]

@xelebofficial Who audits the AI influencer's wallet keys? $62B in synthetic trust is a huge attack surface.